01/10/2025
5:15 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
5:16 PM | DeLucia David (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
4:01 PM | DeLucia David (Reporting)
FibroGen (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
8:15 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
7:00 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
7:00 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
7:00 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
3:52 PM | ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
| Form SC 13G/A | |
11/12/2024
1:33 PM | FibroGen (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
11:11 AM | FibroGen (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/03/2024
3:05 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for FGEN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for FibroGen and its competitors with MarketBeat's FREE daily newsletter. |
09/09/2024
7:00 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
7:00 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
7:00 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
4:05 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
4:10 PM | FibroGen (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/10/2024
11:15 PM | FibroGen (Filer)
| Form EFFECT | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
FibroGen (Subject)
| Form SC 13G/A | |
06/28/2024
4:08 PM | FibroGen (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/26/2024
7:00 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
3:30 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:30 PM | Adib Deyaa (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:37 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:00 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:00 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:12 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
7:00 PM | Blaug Suzanne (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
7:00 PM | EDWARDS JEFFREY L (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
7:00 PM | Brennan Aoife (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
7:00 PM | Cravatt Benjamin (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
7:00 PM | FibroGen (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
7:00 PM | FibroGen (Issuer)
Lema Gerald (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
7:00 PM | FibroGen (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
6:46 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2024
8:55 PM | FibroGen (Filer)
| Form ARS | |
04/24/2024
4:01 PM | FibroGen (Filer)
| Form DEF 14A | |
04/24/2024
4:08 PM | FibroGen (Filer)
| Form DEFA14A | |
04/24/2024
3:15 PM | Adib Deyaa (Reporting)
FibroGen (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/25/2024
4:58 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
6:06 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:17 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Alert: DOGE goes live (Ad) "It's Elon's world, and the rest of us live in it."
Every investor in America is trying to figure out what he might do next. And one widely followed Boston based think tank is stepping forward with their official playbook. Click here to learn more. |
03/08/2024
6:18 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:19 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
7:33 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
7:28 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
7:29 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:37 PM | ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
| Form SC 13G | |
02/05/2024
7:08 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
